Dr. Insogna is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
789 Howard Ave
Bldg
New Haven, CT 06519Phone+1 203-737-1932Fax+1 203-737-2812
Summary
- Dr. Karl Insogna is a tenured Professor at Yale and an internationally recognized expert in the field of metabolic bone disease. He has published widely on the topic in the field's leading scientific journals, is quoted often in the lay press, and has frequently appeared on radio and television. He is a Fellow of the American Association for the Advancement of Science, and was a member of the National Institutes of Health Consensus Conference, which established new recommendations for the optimal level of calcium intake for all Americans - now adopted nationwide. He is a leading researcher in the causes of bone loss in such diseases as osteoporosis and primary hyperparathyroidism, and is currently conducting studies in, among other areas, the role of diet in the development of osteoporosis.
Education & Training
- Yale-New Haven Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1980 - 1982
- University of RochesterResidency, Internal Medicine, 1976 - 1980
- Uconn School Of MedicineClass of 1976
Certifications & Licensure
- CT State Medical License 1980 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
- Elected Member The American Society for Clinical Investigation, 1994
Clinical Trials
- Long-term Nutritional Intervention Study to Determine How Protein Affects Calcium Metabolism Start of enrollment: 2003 May 01
- Calcitonin for Treating X-linked Hypophosphatemia Start of enrollment: 2011 Mar 01
Publications & Presentations
PubMed
- PTH-dependent stabilization of RANKL mRNA is associated with increased phosphorylation of the KH-type splicing regulatory protein.Gang-Qing Yao, Meiling Zhu, Karl Insogna
Molecular and Cellular Endocrinology. 2025-01-01 - Corrigendum to "PTH-dependent stabilization of RANKL mRNA is associated with increased phosphorylation of the KH-type splicing regulatory protein" [Molecul. Cellul. En...Gang-Qing Yao, Meiling Zhu, Karl Insogna
Molecular and Cellular Endocrinology. 2024-11-29 - Item Response Theory Quantifies the Relationship Between Improvements in Serum Phosphate and Patient-Reported Outcomes in Adults With X-Linked Hypophosphatemia.Krina Mehta, Nathalie H Gosselin, Karl Insogna, Olivier Barriere, Emilia Quattrocchi
Clinical Pharmacology and Therapeutics. 2024-11-01
Journal Articles
- A Randomized, Double‐Blind, Placebo‐Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti‐FGF23 Antibody, in Adults with X‐Linked Hypophosphatemia: W...Thomas Weber, Mary D Ruppe, Anthony A Portale, Erik A Imel, Thomas O Carpenter, Karl L Insogna, Farzana Perwad, Pisit Pitukcheewanont, Journal of Bone and Mineral Research
Press Mentions
- Listen to "Peter Tebben Selected as Director of Yale Bone Center"October 7th, 2024
- Discoveries & Impact (March 2023)March 16th, 2023
- Yale Bone Center Celebrates 35 Years of Consistent ProgressApril 14th, 2022
- Join now to see all
Grant Support
- The Role of Sphingosine Kinase in Bone AnabolismNIH2016–2020
- Administrative CoreNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2012
- Targeting Thrombospondin 1 In Bone ResorptionNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2011–2012
- Core Center. Yale Core Center For Musculoskeletal DisordersNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2009–2012
- AGRP Neurons Regulate Bone Remodeling In AgingNational Institute On Aging2011
- Calcitonin For Treating X-Linked HypophosphatemiaNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2011
- Role Of CSF-1 In Osteoclast FunctionNational Institute Of Dental &Craniofacial Research2001–2011
- Role Of CSF-1 In Osteoclast FunctionNational Institute Of Dental &Craniofacial Research2010
- Coloney Stimulating Factor 1 Regulation And Role In BoneNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2010
- Impact Of A Protein Supplement On Bone Mass In Older WomenNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2006–2010
- Conditional Deletion Of Pthrp In Articular ChondrocytesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2007–2008
- The Yale Core Center For Musculoskeletal DisordersNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2004–2008
- Microcomputed Tomography Device (Scanco Microct35)National Center For Research Resources2007
- Role Of IL-6 In Pth-Induced Bone ResorptionNational Institute On Aging2002–2006
- Colony Stimulating Factor 1 Regulation And Role In BoneNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2006
- Evaluation Of Disorders Of Calcium MetabolismNational Center For Research Resources2005
- Dietary Protein'S Effect On Gastric PHNational Center For Research Resources2005
- Soy Protein And Calcium MetabolismNational Center For Research Resources2004–2005
- Long Term Impact Of Protein On Calcium KineticsNational Center For Research Resources2004–2005
- Impact On Dietary Protein On Bone-TurnoverNational Center For Research Resources2004–2005
- Core A: Administrative Core, Pi., Karl InsognaNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2004
- Study To Evaluate Disorders Of CalciumNational Center For Research Resources2004
- Effects Of Single Amino Acid Infusion On The CirculatingNational Center For Research Resources2004
- Dietary Protein'S Effect Of Gastric PHNational Center For Research Resources2004
- Yale Core Center For Musculoskeletal DisordersNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999–2003
- Role For IL6 In PTH Induced Bone ResorptionNational Institute On Aging1998–2001
- Role Of Estrogen In Modulating PTH Induced Cytokine ReleaseNational Center For Research Resources1998–2001
- Interleukin 6 As A Marker For Bone Loss In Primary HyperparathyroidismNational Center For Research Resources1998–2001
- Impact Of Dietary Protein In Bone TurnoverNational Center For Research Resources1996–2001
- Evaluation Of Human Calcium MetabolismNational Center For Research Resources1996–2001
- Impact Of Dietary Protein On Calcium KineticsNational Institute Of Diabetes And Digestive And Kidney Diseases1998–2000
- CSF 1 And Osteoclast FunctionNational Institute Of Dental &Craniofacial Research1998–2000
- Adjunctive 24,25 (OH) 2 Vitamin D3 Therapy In Familial Hyphosphatemic RicketsNational Center For Research Resources1997
- Osteoblast And Pth/Pthrp Bone ResorptionNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1994–1997
- Adjunctive 24,25 (OH) 2-Vitamin D3 Therapy In Familial Hyphosphatemic RicketsNational Center For Research Resources1996
- Malignancy-Associated Pth-Like Peptide--Effect On BoneNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1989–1991
Professional Memberships
- American Society for Bone and Mineral Research (ASBMR)Member
- International Society for Clinical DensitometryMember
- Member
- Member
- National Osteoporosis FoundationBoard of Trustees
- Phi Beta Kappa, Phi Kappa PhiMember
- American Federation for Medical ResearchMember
- International Bone and Mineral SocietyMember
- Connecticut Academy of Science and EngineeringMember
External Links
- Insogna Labhttp://medicine.yale.edu/lab/insogna/
- A Personal Perspective on Clinical Practicehttps://www.youtube.com/watch?v=cvEzQxocRgA
- Research Perspectiveshttps://www.youtube.com/watch?v=ISlw-i1reqk
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: